These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 22932262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer (Vulva Cancer) Committee of Japanese Gynecologic Oncology Group (JGOG).
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [Abstract] [Full Text] [Related]

  • 3. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S, Kumar L, Pandey RM, Upadhyay A, Roy S, Dadhwal V, Madan R, Chander S.
    Asian Pac J Cancer Prev; 2015 Aug; 16(12):5075-9. PubMed ID: 26163644
    [Abstract] [Full Text] [Related]

  • 4. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):243-53. PubMed ID: 26853333
    [Abstract] [Full Text] [Related]

  • 5. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
    Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Gaffney DK.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1179-84. PubMed ID: 22342094
    [Abstract] [Full Text] [Related]

  • 6. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
    Wang JQ, Wang T, Shi F, Yang YY, Su J, Chai YL, Liu Z.
    Asian Pac J Cancer Prev; 2015 Jul 15; 16(14):5957-61. PubMed ID: 26320479
    [Abstract] [Full Text] [Related]

  • 7. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older.
    Hanawa S, Mitsuhashi A, Usui H, Yamamoto N, Watanabe-Nemoto M, Nishikimi K, Uehara T, Tate S, Uno T, Shozu M.
    Int J Gynecol Cancer; 2015 Jun 15; 25(5):891-6. PubMed ID: 25811592
    [Abstract] [Full Text] [Related]

  • 8. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 15; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 9. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S, Köhler C, Burova E, Wlodarczyk W, Jahn U, Grün A, Budach V, Stromberger C.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e137-43. PubMed ID: 21600704
    [Abstract] [Full Text] [Related]

  • 10. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V, Choo BA, Lee KM, Tan TH, Low JH, Ng SY, Ilancheran A, Shen L, Tang J.
    Brachytherapy; 2017 Feb 01; 16(1):126-132. PubMed ID: 27816539
    [Abstract] [Full Text] [Related]

  • 11. Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.
    Jakubowicz J, Blecharz P, Skotnicki P, Reinfuss M, Walasek T, Luczynska E.
    Eur J Gynaecol Oncol; 2014 Feb 01; 35(4):393-9. PubMed ID: 25118480
    [Abstract] [Full Text] [Related]

  • 12. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC, Wang L, Lin JC, Jan JS.
    J Formos Med Assoc; 2015 Mar 01; 114(3):231-7. PubMed ID: 25777974
    [Abstract] [Full Text] [Related]

  • 13. Multi-institutional Observational Study of Prophylactic Extended-Field Concurrent Chemoradiation Therapy Using Weekly Cisplatin for Patients With Pelvic Node-Positive Cervical Cancer in East and Southeast Asia.
    Wakatsuki M, Kato S, Ohno T, Banu PA, Hoang NC, Yadamsuren E, Supriana N, Cao J, Devi CRB, Calaguas MJ, Chansilpa Y, Cho CK, Adylkhanov T, Okonogi N, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2019 Sep 01; 105(1):183-189. PubMed ID: 31125594
    [Abstract] [Full Text] [Related]

  • 14. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Yuxing Y, Devi CR, Bustam AZ, Calaguas MJ, de los Reyes RH, Cho CK, Dung TA, Supriana N, Mizuno H, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):751-7. PubMed ID: 19836154
    [Abstract] [Full Text] [Related]

  • 15. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):817-22. PubMed ID: 9652843
    [Abstract] [Full Text] [Related]

  • 16. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Sause W, Gaffney D, Radiation Therapy Oncology Group (RTOG).
    Int J Radiat Oncol Biol Phys; 2014 Jan 01; 88(1):101-5. PubMed ID: 24331655
    [Abstract] [Full Text] [Related]

  • 17. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
    Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.
    Strahlenther Onkol; 2002 Jul 01; 178(7):378-85. PubMed ID: 12163992
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
    Köhler C, Mustea A, Marnitz S, Schneider A, Chiantera V, Ulrich U, Scharf JP, Martus P, Vieira MA, Tsunoda A.
    Am J Obstet Gynecol; 2015 Oct 01; 213(4):503.e1-7. PubMed ID: 25986030
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.